GILLIS JONATHAN
CAO and Interim CFO
GILLIS JONATHAN has filed 7 SEC Form 4 filings (18 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 19, 2026.
On the most recent filing, GILLIS JONATHAN is listed as CAO and Interim CFO at MapLight Therapeutics, Inc. Inside the rolling window, GILLIS JONATHAN reported no open-market purchases and 6 open-market sales totaling $3.6M in MPLT. The largest disclosed transaction in the window is a sale of 51,900 MPLT shares on Apr 27, 2026, worth $1.5M.
Companies traded
Other insiders at MPLT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GILLIS JONATHAN made?
GILLIS JONATHAN has filed 7 SEC Form 4 filings (18 transaction rows) across 1 company since 2025.
Which companies does GILLIS JONATHAN trade?
GILLIS JONATHAN has filed SEC Form 4 disclosures for 1 company, including MPLT.
When was GILLIS JONATHAN's most recent SEC Form 4 filing?
GILLIS JONATHAN's most recent SEC Form 4 filing on Tracefour is dated Aug 19, 2026.
What is GILLIS JONATHAN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, GILLIS JONATHAN is listed as CAO and Interim CFO.
What is GILLIS JONATHAN's total buy and sell value in the current window?
Inside the rolling retention window, GILLIS JONATHAN bought $0 and sold $3.6M based on SEC Form 4 filings.
What was GILLIS JONATHAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 51,900 MPLT shares on 2026-04-27, worth $1.5M, per SEC Form 4 filings.